Stock MYNZ MAINZ BIOMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Mainz Biomed N.V.

Equities

MYNZ

NL0015000LC2

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.8987 USD +3.42% Intraday chart for Mainz Biomed N.V. -3.49% -22.53%
Apr. 09 Mainz Biomed N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 05 Mainz Biomed N.V. Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic CI

Evolution of the average Target Price on Mainz Biomed N.V.

Price target over the last 5 years

History of analyst recommendation changes

2179e5302543e7f9243a51241.-DgXtt_ygUj-v1NDZdfHs84D_n2OHe9IpQ7xHzFnIUw.mnwhwJuZ2RKS6B4KUY6P9oM0ig_FaKwclj6DXgYPVXiNbE7np6fwfK6SAg~68a37c13aa64217e6288cb3e748f93fe

Analyst Recommendations on Mainz Biomed N.V.

Cantor Fitzgerald Downgrades Mainz Biomed to Neutral From Overweight MT
HC Wainwright Adjusts Mainz Biomed's Price Target to $5 From $9, Keeps Buy Rating MT
HC Wainwright Adjusts Mainz Biomed Price Target to $7 From $10, Maintains Buy Rating MT
Cantor Fitzgerald Adjusts Price Target on Mainz Biomed to $12 From $15, Keeps Overweight Rating MT
HC Wainwright Adjusts Price Target on Mainz Biomed to $10 From $25, Reiterates Buy Rating MT
JonesTrading Initiates Mainz Biomed B.V at Buy With $11 Price Target MT
Cantor Fitzgerald Starts Mainz Biomed at Overweight With $15 Price Target MT
HC Wainwright Initiates Mainz Biomed at Buy With $25 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.8987 USD
Average target price
2 USD
Spread / Average Target
+122.54%
High Price Target
2 USD
Spread / Highest target
+122.54%
Low Price Target
2 USD
Spread / Lowest Target
+122.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Mainz Biomed N.V.

Cantor Fitzgerald
HC Wainwright
JonesTrading Institutional Services

Ratings for Mainz Biomed N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MYNZ Stock
  4. Consensus Mainz Biomed N.V.